Cyclic adenosine monophosphate (cAMP)-induced histone hyperacetylation Contributes to its antiproliferative and differentiation-inducing activities

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 67 C, Issue 3-4, 2012, Pages 222-232

  Yoo, Seungwan ^a,b   Lee, Yong Gyu ^c   Kim, Ji Hye ^a   Byeon, Se Eun ^a   Rho, Ho Sik ^d   Cho, Jae Youl ^a   Hong, Sungyoul ^a  

^a Sungkyunkwan University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

^c Kangwon National University   (South Korea)

^d AmorePacific Corporation   (South Korea)

Author keywords

Antiproliferative effect; Cyclic AMP; Histone acetylation

Indexed keywords

EID: 84860434170     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.1515/znc-2012-3-415     Document Type: Article

References (44)

1. Allfrey V. G., Faulkner R., and Mirsky A. E. (1964), Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc. Natl. Acad. Sci. USA 51, 786-794.
2. Aschner M. (1998), Astrocytes as mediators of immune and inflammatory responses in the CNS. Neurotoxicology 19, 269-281.
3. Balakin K. V., Ivanenkov Y. A., Kiselyov A. S., and Tkachenko S. E. (2007), Histone deacetylase inhibitors in cancer therapy: latest developments, trends and medicinal chemistry perspective. Anticancer Agents Med. Chem. 7, 576-592.
4. Benda P., Lightbody J., Sato G., Levine L., and Sweet W. (1968), Differentiated rat glial cell strain in tissue culture. Science 161, 370-371.
5. Bhattacharjee M., Sarkar S., Dutta S., Begum Z., Roy U. R., Chaudhuri S., and Chaudhuri S. (2004), Differential regulation of the protein tyrosine kinase activity following interleukin-2 (IL-2), interferon gamma (IFN-gamma) and SRBC administration in brain tumor-induced conditions: SRBC acting as a dual potentiator in regulating the cytokine profile. Cancer Biol. Ther. 3, 755-760.
6. Bjorge J. D., Pang A. S., Funnell M., Chen K. Y., Diaz R., Magliocco A. M., and Fujita D. J. (2011), Simultaneous siRNA targeting of Src and downstream signaling molecules inhibit tumor formation and metastasis of a human model breast cancer cell line. PLoS One 6, e19309.
7. Butler L. M., Webb Y., Agus D. B., Higgins B., Tolentino T. R., Kutko M. C., LaQuaglia M. P., Drobnjak M., Cordon-Cardo C., Scher H. I., Breslow R., Richon V. M., Rifkind R. A., and Marks P. A. (2001), Inhibition of transformed cell growth and induction of cellular differentiation by pyroxamide, an inhibitor of histone deacetylase. Clin. Cancer Res. 7, 962-970.
8. Chen H. H., Chien C. H., and Liu H. M. (1994), Correlation between angiogenesis and basic fibroblast growth factor expression in experimental brain infarct. Stroke 25, 1651-1657.
9. Chen C. C., Chang J., and Chen W. C. (1996), Potentiation of bradykinin-induced inositol phosphates production by cyclic AMP elevating agents and endothelin-1 in cultured astrocytes. Glia 16, 210-217.
10. Cho-Chung Y. S. (1990), Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy. Cancer Res. 50, 7093-7100.
11. Chung I. M., Lim J. W., Pyun W. B., and Kim H. (2010a), Korean red ginseng improves vascular stiffness in patients with coronary artery disease. J. Ginseng Res. 34, 212-218.
12. Chung S. H., Yuan H. D., Kim S. J., Quan H. Y., and Huang B. (2010b), Ginseng leaf extract prevents high fat diet-induced hyperglycemia and hyperlipidemia through AMPK activation. J. Ginseng Res. 34, 369-375.
13. Countryman J. K., Gradoville L., and Miller G. (2008), Histone hyperacetylation occurs on promoters of lytic cycle regulatory genes in Epstein-Barr virusinfected cell lines which are refractory to disruption of latency by histone deacetylase inhibitors. J. Virol. 82, 4706-4719.
14. Dahl D. (1981), The vimentin-GFA protein transition in rat neuroglia cytoskeleton occurs at the time of myelination. J. Neurosci. Res. 6, 741-748.
15. Dahl D., Zapatka S., and Bignami A. (1986), Heterogeneity of desmin, the muscle-type intermediate fila ment protein, in blood vessels and astrocytes. Histochemistry 84, 145-150.
16. Davie J. R., Sun J. M., Spencer V. A., Chen H. Y., and Li L. (2003), Measurement of histone acetyltransferase and histone deacetylase activities and kinetics of histone acetylation. Methods 31, 12-23.
17. Engelhard H. H., Duncan H. A., Kim S., Criswell P. S., and Van Eldik L. (2001), Therapeutic effects of sodium butyrate on glioma cells in vitro and in the rat C6 glioma model. Neurosurgery 48, 616-624; 624-615 (discussion).
18. Hishiki T., Saito T., Sato Y., Mitsunaga T., Terui E., Matsuura G., Saito E., Shibata R., Mise N., Yokoyama Y., and Yoshida H. (2011), Src kinase family inhibitor PP2 induces aggregation and detachment of neuroblastoma cells and inhibits cell growth in a PI3 kinase/Akt pathway-independent manner. Pediatr. Surg. Int. 27, 225-230.
19. Hong L., Schroth G. P., Matthews H. R., Yau P., and Bradbury E. M. (1993), Studies of the DNA binding properties of histone H4 amino terminus. Thermal denaturation studies reveal that acetylation markedly reduces the binding constant of the H4 "tail" to DNA. J. Biol. Chem. 268, 305-314.
20. Johnstone R. W. and Licht J. D. (2003), Histone deacetylase inhibitors in cancer therapy: is transcription the primary target? Cancer Cell 4, 13-18.
21. Joung K. E., Min K. N., Kim D. K., and Sheen Y. Y. (2012), Anti-cancer effect of IN-2001 in T47D human breast cancer. Biomol. Ther. 20, 81-88.
22. Jun H. S., Cha J. Y., Park E. Y., Kim H. J., Park S. U., Nam K. Y., and Choi J. E. (2010), Effect of white, taegeuk, and red ginseng root extracts on insulin-stimulated glucose uptake in muscle cells and proliferation of beta-cells. J. Ginseng Res. 34, 192-197.
23. Kamitani H., Taniura S., Watanabe K., Sakamoto M., Watanabe T., and Eling T. (2002), Histone acetylation may suppress human glioma cell proliferation when p21 WAF/Cip1 and gelsolin are induced. Neuro. Oncol. 4, 95-101.
24. Kim J. Y., Lee Y. G., Kim M. Y., Byeon S. E., Rhee M. H., Park J., Katz D. R., Chain B. M., and Cho J. Y. (2010), Src-mediated regulation of inflammatory responses by actin polymerization. Biochem. Pharmacol. 79, 431-443.
25. Ko K. H., Lee S. H., Go H. S., Choi C. S., Cheong J. H., Han S. Y., Bae K., and Park S. H. (2010), Inhibitory effects of phylligenin on the proliferation of cultured rat neural progenitor cells. Biomol. Ther. 18, 48-55.
26. Kumar S., Holmes E., Scully S., Birren B. W., Wilson R. H., and de Vellis J. (1986), The hormonal regulation of gene expression of glial markers: glutamine synthetase and glycerol phosphate dehydrogenase in primary cultures of rat brain and in C6 cell line. J. Neurosci. Res. 16, 251-264.
27. Li X. N., Shu Q., Su J. M., Perlaky L., Blaney S. M., and Lau C. C. (2005), Valproic acid induces growth arrest, apoptosis, and senescence in medulloblastomas by increasing histone hyperacetylation and regulating expression of p21Cip1, CDK4, and CMYC. Mol. Cancer Ther. 4, 1912-1922.
28. Liu S. and Yamauchi H. (2009), p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function. Cancer Lett. 286, 240-249.
29. Mangoura D., Sakellaridis N., Jones J., and Vernadakis A. (1989), Early and late passage C-6 glial cell growth: similarities with primary glial cells in culture. Neurochem. Res. 14, 941-947.
30. Moreno M. J., Ball M., Andrade M. F., McDermid A., and Stanimirovic D. B. (2006), Insulin-like growth factor binding protein-4 (IGFBP-4) is a novel antiangiogenic and anti-tumorigenic mediator secreted by dibutyryl cyclic AMP (dB-cAMP)-differentiated glioblastoma cells. Glia 53, 845-857.
31. Mucke L. and Eddleston M. (1993), Astrocytes in infectious and immune-mediated diseases of the central nervous system. FASEB J. 7, 1226-1232.
32. Nagaraj N. S., Smith J. J., Revetta F., Washington M. K., and Merchant N. B. (2010), Targeted inhibition of Src kinase signaling attenuates pancreatic tumorigenesis. Mol. Cancer Ther. 9, 2322-2332.
33. Parker K. K., Norenberg M. D., and Vernadakis A. (1980), "Transdifferentiation" of C6 glial cells in culture. Science 208, 179-181.
34. Rhee D. K., Kim E. H., Lee M. J., Kim I. H., Pyo S., and Choi K. T. (2010), Anti-apoptotic effects of red ginseng on oxidative stress induced by hydrogen peroxide in SK-N-SH cells. J. Ginseng Res. 34, 138-144.
35. Rosato R. R., Almenara J. A., Dai Y., and Grant S. (2003), Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells. Mol. Cancer Ther. 2, 1273-1284.
36. Roymans D., Willems R., Vissenberg K., De Jonghe C., Grobben B., Claes P., Lascu I., Van Bockstaele D., Verbelen J. P., Van Broeckhoven C., and Slegers H. (2000), Nucleoside diphosphate kinase beta (Nm23- R1/NDPKbeta) is associated with intermediate filaments and becomes upregulated upon cAMP- induced differentiation of rat C6 glioma. Exp. Cell Res. 261, 127-138.
37. Sarg B., Helliger W., Talasz H., Koutzamani E., and Lindner H. H. (2004), Histone H4 hyperacetylation precludes histone H4 lysine 20 trimethylation. J. Biol. Chem. 279, 53458-53464.
38. Stautz D., Sanjay A., Hansen M. T., Albrechtsen R., Wewer U. M., and Kveiborg M. (2010), ADAM12 localizes with c-Src to actin-rich structures at the cell periphery and regulates Src kinase activity. Exp. Cell Res. 316, 55-67.
39. Tarui T., Fukami K., Nagasawa K., Yoshida S., Sekiguchi F., and Kawabata A. (2010), Involvement of Src kinase in T-type calcium channel-dependent neuronal differentiation of NG108-15 cells by hydrogen sulfide. J. Neurochem. 114, 512-519.
40. Thomas E. A., Matli J. R., Hu J. L., Carson M. J., and Sutcliffe J. G. (2000), Pertussis toxin treatment prevents 5-HT(5a) receptor-mediated inhibition of cyclic AMP accumulation in rat C6 glioma cells. J. Neurosci. Res. 61, 75-81.
41. Weinstein D. E., Shelanski M. L., and Liem R. K. (1991), Suppression by antisense mRNA demonstrates a requirement for the glial fibrillary acidic protein in the formation of stable astrocytic processes in response to neurons. J. Cell Biol. 112, 1205-1213.
42. Winograd-Katz S. E., Brunner M. C., Mirlas N., and Geiger B. (2010), Analysis of the signaling pathways regulating Src-dependent remodeling of the actin cytoskeleton. Eur. J. Cell Biol. 90, 143-156.
43. Yang X. J., Pelletier N., Champagne N., and Lim H. (2003), Expression, purification, and analysis of MOZ and MORF histone acetyltransferases. Methods 31, 24-32.
44. Yang D. C., Kim Y. J., Lee J. H., Lee O. R., Shim J. S., Jung S. K., Son N. R., Kim J. H., and Kim S. Y. (2010), Isolation and characterization of a type II peroxiredoxin gene from Panax ginseng C. A. Meyer. J. Ginseng Res. 34, 296-303.